Identification of a novel fusion gene involving hTAF(II)68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma

Citation
C. Attwooll et al., Identification of a novel fusion gene involving hTAF(II)68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma, ONCOGENE, 18(52), 1999, pp. 7599-7601
Citations number
17
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ONCOGENE
ISSN journal
09509232 → ACNP
Volume
18
Issue
52
Year of publication
1999
Pages
7599 - 7601
Database
ISI
SICI code
0950-9232(199912)18:52<7599:IOANFG>2.0.ZU;2-B
Abstract
A proportion of extraskeletal myxoid chondrosarcomas (EMC) have been shown to have a characteristic translocation t(9;22)(q22;q12) involving the EWS g ene at 22q12 and the CHN orphan nuclear receptor gene at 9q22, This translo cation appears to be largely specific for EMC, but has not been detected in all such tumours. We report here a case of EMC with a t(9;17)(q22;q11.2) a s the sole chromosome abnormality. We have determined that the translocatio n results in the fusion of the entire coding region of CHN to the N-termina l transactivation domain of RBP56/hTAF(II)68. This is the first report of a translocation involving RBP56/hTAF(II) 68, a protein with sequence homolog y to both EWS and TLS/FUS, The involvement of RBP56/hTAF(II)68 may explain some unusual features of the tumour.